Plain-English translation of NCT06553976 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This is a research registry and natural history study for people diagnosed with hereditary spastic paraplegia (specifically types SPG4 or SPG5A) or primary lateral sclerosis. Researchers are building a centralized network across multiple hospitals and countries to collect clinical information, biological samples, and genetic data. This shared resource will help doctors better understand these rare neurological conditions and speed up development of new treatments.
Hereditary spastic paraplegia and primary lateral sclerosis are rare inherited conditions that cause progressive muscle weakness and stiffness, but there is currently no coordinated way for researchers worldwide to study them together. By creating a shared registry and sample bank, this study aims to standardize how these conditions are measured and studied, making it easier to run clinical trials and discover better treatments in the future.
You likely qualify if…
You likely don't qualify if…
As a participant, you would share your medical history and clinical information with the research network, and you may be asked to donate blood or other biological samples. You would likely have periodic visits or check-ins at one of the participating medical centers, where researchers will collect data about your condition and symptoms over time. The exact schedule and details would be explained by the study team at your location, but the goal is to build a long-term database that helps researchers worldwide understand these conditions better.
AI-generated summary from trial data · Jun 1, 2026 · Not medical advice
United States